Synthetic Biologics Inc. (NYSEAMERICAN: SYN) Enters Definitive Agreement To Acquire CVN...

Max - 0

Global Blood Therapeutics Inc. (NASDAQ: GBT) Presents GBT601 Study and Oxbryta...

Max - 0

Arbutus Biopharma Corporation (NASDAQ: ABUS) and Antios Therapeutics Inc. Dose First...

Max - 0

Cidara Therapeutics Inc. (NASDAQ: CDTX) and Mundipharma Report Positive ReSTORE Phase...

Max - 0

Aptose Biosciences Inc.’s (NASDAQ: APTO) HM43239 Shows Durable Activity In Refractory/Relapsed...

Max - 0

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Receives IND Clearance For TNX-2100...

Max - 0

US FDA Accepts Ocugen Inc.’s (NASDAQ: OCGN) Investigational New Drug Application...

Max - 0

Adagio Therapeutics Inc. (NASDAQ: ADGI) Offers Update About In Vitro Analysis...

Max - 0

Galera Therapeutics Inc. (NASDAQ: GRTX) Announced Updated Findings Of Phase 3...

Max - 0

Pasithea Therapeutics Corp (NASDAQ: KTTA) Expands IV Ketamine Therapy Availability In...

Max - 0
1...888990...248Page 89 of 248